Thorp Clay

Insider Buys Quantity –
8
2023-09-25PurchaseClearside Biomedical, Inc.
CLSD
director
10,000
0.0163%
$0.86$8,600+47.06%
2022-12-21PurchaseClearside Biomedical, Inc.
CLSD
director
14,000
0.0236%
$1.02$14,266+7%
2022-05-16PurchaseVigil Neuroscience, Inc.
VIGL
14,893
0.0551%
$2.97$44,189+235.79%
2022-03-28PurchaseVigil Neuroscience, Inc.
VIGL
3,000
0.0114%
$7.20$21,604+25.92%
2022-01-11PurchaseVigil Neuroscience, Inc.
VIGL
director
265,000
1.1733%
$14.00$3.71M-24.96%
2021-02-10SaleClearside Biomedical, Inc.
CLSD
director
32,873
0.0601%
$4.43$145,627-17.88%
2018-12-06PurchaseClearside Biomedical, Inc.
CLSD
8,000
0.0251%
$1.36$10,880-17.02%
2018-05-30SaleG1 Therapeutics, Inc.
GTHX
10 percent owner
1.6M
5.1007%
$48.00$76.8M-19.16%
2018-05-23SaleG1 Therapeutics, Inc.
GTHX
10 percent owner
1,000
0.0031%
$50.50$50,500-23.04%
2018-05-22SaleG1 Therapeutics, Inc.
GTHX
10 percent owner
11,800
0.0371%
$50.85$600,032-22.75%
2018-05-21SaleG1 Therapeutics, Inc.
GTHX
10 percent owner
62,200
0.1907%
$51.16$3.18M-24.88%
2018-05-18SaleClearside Biomedical, Inc.
CLSD
61,139
0.1932%
$13.16$804,589-86.33%
2018-05-17SaleClearside Biomedical, Inc.
CLSD
100,000
0.3125%
$13.03$1.3M-86.2%
2018-03-23SaleClearside Biomedical, Inc.
CLSD
5,231
0.02%
$12.02$62,877-46.77%
2018-03-22SaleClearside Biomedical, Inc.
CLSD
33,630
0.1291%
$12.07$405,914-46.42%
2018-03-21SaleClearside Biomedical, Inc.
CLSD
100,000
0.3763%
$12.27$1.23M-48.27%
2017-12-07SaleClearside Biomedical, Inc.
CLSD
5,000
0.0195%
$6.13$30,650+11.94%
2017-12-06SaleClearside Biomedical, Inc.
CLSD
15,000
0.0605%
$6.09$91,350+16.25%
2017-12-05SaleClearside Biomedical, Inc.
CLSD
15,000
0.0611%
$6.37$95,550+12.39%
2017-11-16SaleClearside Biomedical, Inc.
CLSD
5,000
0.0198%
$6.99$34,950+1.51%